Biology subjects

Mandel, G.

Publications and source records attributed to Mandel, G..

5 recordsLinked to original sources

bioRxiv2026

Collateral sensitivities with predictive signatures emerge in a novel model of evolved chemoresistance in osteosarcoma

Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. Despite aggressive multimodal therapy, including surgery and chemotherapy with methotrexate, doxorubicin, and cisplatin (MAP), outcomes for patients with relapsed or refractory disease remain poor, with no standardized second-line regimen. We developed a clinically calibrated, temporally resolved in vitro model to examine how resistance and collateral drug responses evolve during treatment with methotrexate, doxorubicin, and cisplatin (MAP). We modeled the evolution of chemotherapy resistance in vitro by exposing an OS cell line, MG63.3, to clinically relevant cycles of MAP therapy. MAP resistance and collateral drug responses were quantified over time across five independent evolutionary replicates, and three solvent-treated replicates served as controls. We complemented this phenotypic screening with transcriptomic profiling to extract predictive biomarkers of collateral drug response that could be used to personalize second-line treatment in patients with refractory OS. MAP exposure produced progressive resistance to doxorubicin and methotrexate, whereas cisplatin sensitivity remained comparatively stable. Repeated temporal screening against 12 additional drugs and combinations revealed three broad patterns of collateral response: progressive resistance, progressive sensitivity, and non-linear or stochastic change. Etoposide resistance emerged consistently, while sensitivity developed toward palifosfamide-etoposide and gemcitabine-docetaxel. Transcriptomic profiling showed dynamic, replicate-specific evolutionary trajectories rather than a single uniform resistance state. To demonstrate one approach for how our large, paired dataset could be used to translate these findings into potentially actionable clinical tools, we extracted predictive gene expression signatures of collateral drug response. By applying a dynamic, clinically inspired model of chemotherapy resistance in OS, we generated a detailed temporal mapping of collateral drug responses that highlights potential therapeutic windows and can be used inform selection of second-line agents. This approach and the resulting dataset can ultimately support personalized medicine strategies for patients with relapsed or refractory OS.

cancer biology↗

bioRxiv2026

Early postnatal DNA methylation dynamics define neuronal subtypes and are disrupted by MECP2 loss

DNA methylation is the foundational layer of epigenetic regulation underlying mammalian tissue specification. During synaptogenesis, neurons accumulate high levels of a unique type of methylation in which a cytosine precedes a C, A, or T (mCH) instead of the canonical guanine (mCG). Disruption of the mCH reader methyl-CpG binding protein 2 (MECP2) causes the devastating neurodevelopmental disorder Rett syndrome, yet the role of mCH in neurodevelopment remains unclear. In this study, we generated the first large-scale single-cell methylation atlas of the early postnatal mouse brain and resolved subtype-specific trajectories of canonical and noncanonical methylation changes underlying neuronal subtype specification. Each identified population undergoes a rapid maturation event of the noncanonical methylome occurring between the first and second postnatal weeks, with highly subtype-specific changes concentrated at genes involved in synaptic partner establishment. Trajectory analysis resolved that subtype diversification, such as the separation of parvalbumin and somatostatin-positive GABAergic interneurons, is further facilitated by a hierarchical sequence of methylation changes in genes involved in regulation of membrane potential. In parallel, we applied single-cell methylation analysis to a mouse model of Rett syndrome that recapitulates severe human symptoms. We show that while noncanonical methylation accumulation proceeds in each subtype in the absence of MECP2, populations that have been consistently implicated in Rett pathology such as GABAergic interneurons have an increasing number of differentially methylated regions with age and fail to accumulate typical global levels of mCH. Together, our study defines the methylation dynamics that facilitate neuronal subtype specification and resolves subtype-specific, global disruptions of noncanonical methylation in Rett syndrome.

neuroscience↗

bioRxiv2020

Genome-wide assessment of REST binding profiles reveals distinctions between human and mouse hippocampus

Background The transcriptional repressor, RE1 Silencing Transcription Factor (REST), recognized historically as a master regulator of neuronal gene expression during mouse development, has recently been ascribed roles in human aging and neurodegenerative disorders. However, REST’s role in healthy adult human brain, and how faithfully mouse models reproduce REST function in human brain, is not known.Results Here, we present the first genome-wide binding profile for REST in both mouse and human postnatal hippocampus. We find the majority of REST-bound sites in human hippocampus are unique compared to both mouse hippocampus and to all other reported human ENCODE cell types. Genes associated with unique REST-bound sites include previously unidentified categories related to innate immunity and inflammation signaling, suggesting species specific roles for REST in protecting human brain health.Conclusions Our results suggest newly evolved functions for REST in maintaining human brain health.Competing Interest StatementThe authors have declared no competing interest.View Full Text

genomics↗

bioRxiv2020

In vivo repair of a protein underlying a neurological disorder by programmable RNA editing

RNA base editing is gaining momentum as an approach to repair mutations, but its application to neurological disease has not been established. We have succeeded in directed transcript editing of a pathological mutation in a mouse model of the neurodevelopmental disease, Rett syndrome. Specifically, we directed editing of a guanosine to adenosine mutation in RNA encoding Methyl CpG Binding Protein 2 (MECP2). Repair was mediated by injecting the hippocampus of juvenile Rett mice with an adeno-associated virus expressing both an engineered enzyme containing the catalytic domain of Adenosine Deaminase Acting on RNA 2 and a Mecp2 targeting guide. After one month, 50% of Mecp2 RNA was recoded in three different hippocampal neuronal subtypes, and the ability of MeCP2 protein to associate with heterochromatin was similarly restored to 50% of wild-type levels. This study represents the first in vivo programmable RNA editing applied to a model of neurological disease.

neuroscience↗

bioRxiv2018

The accessible chromatin landscape of the hippocampus at single-cell resolution

Here we present a comprehensive map of the accessible chromatin landscape of the mouse hippocampus at single-cell resolution. Substantial advances of this work include the optimization of single-cell combinatorial indexing assay for transposase accessible chromatin (sci-ATAC-seq), a software suite, scitools, for the rapid processing and visualization of single-cell combinatorial indexing datasets, and a valuable resource of hippocampal regulatory networks at single-cell resolution. We utilized sci-ATAC-seq to produce 2,346 high-quality single-cell chromatin accessibility maps with a mean unique read count per cell of 29,201 from both fresh and frozen hippocampi, observing little difference in accessibility patterns between the preparations. Using this dataset, we identified eight distinct major clusters of cells representing both neuronal and non-neuronal cell types and characterized the driving regulatory factors and differentially accessible loci that define each cluster. We then applied a recently described co-accessibility framework, Cicero, which identified 146,818 links between promoters and putative distal regulatory DNA. Identified co-accessibility networks showed cell-type specificity, shedding light on key dynamic loci that reconfigure to specify hippocampal cell lineages. Lastly, we carried out an additional sci-ATAC-seq preparation from cultured hippocampal neurons (899 high-quality cells, 43,532 mean unique reads) that revealed substantial alterations in their epigenetic landscape compared to nuclei from hippocampal tissue. This dataset and accompanying analysis tools provide a new resource that can guide subsequent studies of the hippocampus.

neuroscience↗